The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Blood Loss
Interventions
DRUG

Hemostatic Matrix

FloSeal will be administered following the cementing of all knee components. Prior to release of the tourniquet and after the cement has cured, it will be applied to cut, exposed bone ends as well as the intra-articular soft tissues by the use of a delivery syringe, Direct manual pressure with a gauze sponge will be applied following its application for 2 minutes, ensuring that it adheres to the bleeding bone surface.

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Hospital for Special Surgery, New York

OTHER

NCT00990288 - The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery | Biotech Hunter | Biotech Hunter